From Plant Press, Vol. 26, No. 1, January 2023.
By W. John Kress
The Fifteenth Conference of the Parties (COP) of the Convention on Biological Diversity (CBD) in Montreal was held on 6-19 December 2022. I spent the first week physically in Montreal as an Observer at COP representing both the Earth BioGenome Project and the DSI Scientific Network, and the second week monitoring the conference virtually. Below are my notes and impression of the proceedings.
Report on first week
These first days have been packed with plenaries, regional meetings, contact groups, friends of the co-chairs, summits, side events, focus groups, presentations, informal discussions, and outside protests. With over 1,800 participants representing 193 countries, the venue is bursting. It is clear that one thing is on everyone’s mind: biodiversity. The four goals of the CBD are the conservation of biodiversity, the sustainable use of biodiversity, the equitable access and benefit sharing of biodiversity (especially genetic resources and digital sequence information), and the identification of adequate financial resources for implementation. Swirling around these four core goals are issues of climate change, protected areas, the global public good, capacity building, indigenous peoples and local communities, genetic resources, digital sequence information, business and finance, and on and on. Of course, everyone has an opinion and a position on each issue.
This first week is about information sharing, staking out positions, and building allies. Those of us who are “Observers” are primarily trying to provide the necessary information for the national delegates to make informed decisions when the hardcore negotiations take place next week. All options seem to be on the table right now with regards to many of the 20+ targets under consideration.
I am here in Montreal representing “Academia and Research” as an Observer for the Earth BioGenome Project (EBP), an international initiative aimed at generating genomic information for all species currently on Earth, about 1.8 million species. Most of my time is being spent in discussions on figuring out the best means to access genetic resources around the world, generate digital sequence information (DSI) from those samples, share the genomic data in an open and free system, and ensure that benefits (both monetary and non-monetary) flow back to the regions where those genetic resources originated. It is not clear at this point what the solution will be. From the scientific perspective, open access and multilateral regulation with free public data sharing is by far the best course of action. But many viewpoints prevail.